Simile, founded in 2022 by Stanford PhD researchers, operates an AI simulation platform designed to model human decision-making. The company's core technology creates digital twins that reproduce human responses, enabling enterprises to test product launches, pricing changes, marketing campaigns, and policy decisions before real-world implementation. Its proprietary foundation model for human behavior reports an 85% accuracy rate in reproducing these responses.
The platform is used by a range of large enterprises, including CVS Health, Gallup, Wealthfront, Suntory, and Itaú. The company's technical work spans AI simulation, human behavior modeling, and generative agents, with its research on the latter - specifically the 'Smallville' study - garnering over 7,200 citations. The platform processes over 7,000 evaluations weekly.
Simile has raised $300 million in funding, achieving a valuation of $2 billion. The company's stated mission is to simulate all eight billion people on Earth, an objective that evolved from its academic research origins.
